Celgene (NSDQ:CELG) said this week that it has made another investment in GNS Healthcare and inked a deal with the bioanalytics firm for its “Reverse Engineering and Forward Simulation” software. GNS’s software analyzes health data, including electronic health records, pharmacy claims and genomic sequences, and uses machine learning to answer questions in healthcare. The multi-year agreement […]